Today in the UK1 and Ireland2, nearly 2 million people are living with psoriasis.
Recognising that much still needs to change in the care of people living with psoriasis, a group of patients, healthcare professionals and charities have joined together to fight back against psoriasis.
The PSO What? Report, led by the Patients Association and LEO Pharma in collaboration with the expert PSO What? Taskforce, shows that psoriasis is far from ‘just a skin condition’.
Action needs to be taken now by patients, healthcare professionals and the public. Watch the video to hear how you can make a difference.
LEO Pharma has provided core funding, editorial input and undertaken survey-based research to support the development of the PSO What? Report.
Find out more about the PSO What? Report on our social media channels
Patients Association telephone helpline: 020 8423 8999
References:1. Mental Health Foundation, Psoriasis Association. See psoriasis: look deeper. Recognising the life impact of psoriasis. 2012.
2. Irish Skin Foundation. The burden of psoriasis. Epidemiology, quality of life, comorbidities and treatment goals. 2015.
3. Data on file. LEO Pharma. DERM-004 MAR 2017
UK/IE/Mat-08293, September 2018
PSO What? is the reality of psoriasis care
A survey commissioned for the PSO What? Report shows that psoriasis negatively affects the quality of life of 93% of the people surveyed, but a third of people with the condition do not regularly visit their GP each year – many suffer in silence.1
All people living with psoriasis deserve regular reviews with a healthcare professional – at least annually – to ensure they can access the best psoriasis care possible and screen for further complications. Pledge to make this standard practice across the UK and Ireland.
All people living with psoriasis deserve regular reviews with a healthcare professional – at least annually – to ensure they can access the best psoriasis care possible and screen for further complications. Pledge to make this standard practice across the UK and Ireland.